FDA Inspection 1295344 — Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
The FDA completed an inspection of Hubei Gedian Humanwell Pharmaceutical Co., Ltd. on November 7, 2025 in Ezhou. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- November 7, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ezhou (China)